Argatroban Monohydrate CAS 141396-28-3 Kuchena ≥99.0% API Factory High Purity
Manufacturer SupplyArgatroban Related Intermediates:
Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4
Argatroban Monohydrate CAS 141396-28-3
Argatroban Anhydrous CAS 74863-84-6
| Chemical Name | Argatroban Monohydrate |
| Nhamba yeCAS | 141396-28-3 |
| Nhamba yeCAT | RF-API66 |
| Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Mazana emaKilogram |
| Molecular Formula | C23H38N6O6S |
| Molecular Weight | 526.65 |
| Solubility | DMSO |
| Shipping Condition | Yakatumirwa Pasi peAmbient Temperature |
| Brand | Ruifu Chemical |
| Item | Zvinotsanangurwa |
| Chitarisiko | Ichena kana Isina-White Crystalline Powder |
| Identification | Positive Reaction |
| Melting Point | 166.0-170.0°C |
| Kujeka Kwemhinduro | Solution Inofanira Kujeka isina Ruvara |
| Kuchena | ≥99.0% |
| Enantiomorph | ≤0.10% |
| Specific Rotation | +175.0 ° kusvika +185.0 ° |
| Kusachena Kumwechete | ≤0.50% |
| Zvose Zvisina Kuchena | ≤1.0% |
| Mvura | 2.5%~4.5% |
| Residue paIgnition | ≤0.10% |
| Heavy Metals | ≤10ppm |
| Chloride | ≤0.015% |
| Microbial Limit | TAMC NMT 1000 cfu/g |
| Test Standard | Enterprise Standard |
| Usage | API, Synthetic Antithrombotic Agent |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.
Shanghai Ruifu Chemical Co., Ltd. ndiyo inotungamira mugadziri uye mutengesi weArgatroban Monohydrate (CAS: 141396-28-3) ine mhando yepamusoro.Argatroban is synthetic anticoagulant inoshanda seine simba, inosarudza, univalent yakananga inhibitor yethrombin.Argatroban yakagamuchirwa muna 2000 yeprophylaxis kana kurapwa kwethrombosis kune varwere vane heparin-induced thrombocytopenia (HIT).Argatroban is a new synthetic antithrombotic agent inobatsira mukuchengetedza anticoagulation ivo ischemic sitiroko uye kuparadzira intravascular coagulation.
